Nick Jonas Writes Open Letter on Type 1 Diabetes
The singer shared his 21-year experience living with the condition as part of Dexcom's A Letter to Diabetes initiative.
U.S. Diabetes News
This section covers diabetes in the United States — management, treatment advances, prevention research and the public health dimensions of a condition affecting a large share of the population. Reporting takes in both the science and the policy and economic conditions surrounding the disease.
Recent news
November 8, 2026
Red Cross Offers Free A1C Testing to DonorsBlood donors who give successfully in November 2026 can receive a free A1C test during Diabetes Awareness Month.
November 8, 2026
Study Links GLP-1 Drugs to Lower Cancer RiskA JAMA Network Open study compares obesity-related cancer rates among Type 2 diabetes patients using GLP-1 medications and other diabetes treatments.
November 7, 2026
Study Finds Diabetes Risk in South Asian AdultsResearch shows South Asian adults in the US face metabolic diabetes risk even with normal body mass index.
November 7, 2026
Resmetirom Eases Worry in Cirrhosis PatientsA post hoc analysis of the MAESTRO-NAFLD-1 trial links the MASH drug to better mental health outcomes in compensated cirrhosis.
November 6, 2026
Ms. Rachel Urges Talarico to Aid Diabetic ChildrenThe children's entertainer congratulated the Texas Senate winner and asked him to advocate for diabetic children in Gaza who need medication.
November 6, 2026
Acmopatide Trial Shows Gains in Type 1 DiabetesA Phase 2 study found acmopatide improved blood sugar control and body weight in adults with type 1 diabetes and overweight or obesity.
November 6, 2026
Lollipop Sensor Detects Acetaminophen in SalivaA prototype device returns acetaminophen readings from saliva in under two minutes, though it has not yet been validated for clinical use.
November 6, 2026
GLP-1 Drugs Linked to Fewer Psychiatric AdmissionsA US cohort study found adults with schizophrenia and Type 2 diabetes who started GLP-1 receptor agonists had lower rates of psychiatric hospitalization.
November 6, 2026
Diet and Exercise Benefits Persist for Older AdultsLong-term follow-up of the Look AHEAD trial shows continued advantages in older adults with type 2 diabetes despite no cardiovascular effect.
November 6, 2026
Blood Test Shows Promise for Pancreatic InsufficiencyA pilot study presented at the ACG Annual Scientific Meeting found a blood-based biomarker performed comparably to fecal elastase in diagnosing exocrine pancreatic insufficiency.
More in Diabetes
Treatment approvals and their clinical evidence, blood sugar monitoring technology developments, prevention research and dietary findings, prevalence data releases and the medication access and affordability questions that affect how people manage the condition are the central subjects here. New York, Los Angeles, Chicago, Houston and Phoenix are among the metropolitan areas where diabetes rates and health system capacity to manage the condition receive sustained public health attention, and coverage draws on conditions in those cities when reporting on the national picture. Medication affordability — particularly for insulin and the newer drug classes used in diabetes management — has become a consistently prominent coverage subject given the direct effect of drug pricing on how people with the condition manage it day to day. Type 1 and Type 2 research proceed on separate scientific tracks, and coverage of each follows distinct clinical and policy timelines that rarely converge.